June 10, 2019 Bruce Rogers, Ph.D. Dear Bruce:Offer Letter • June 14th, 2019 • Morphic Holding, Inc. • Pharmaceutical preparations
Contract Type FiledJune 14th, 2019 Company IndustryThis letter agreement amends and restates the offer letter between you and Morphic Holding, Inc. (the “Company”)1, dated December 10, 2015 (the “Prior Agreement”), effective as of the date immediately prior to the first date on which the Registration Statement on Form S-1 for the initial public offering of the Company’s common stock is declared effective by the United States Securities and Exchange Commission or, if later, the date that this Agreement is signed.
June 10, 2019 Praveen Tipirneni, MD Dear Praveen:Offer Letter • June 14th, 2019 • Morphic Holding, Inc. • Pharmaceutical preparations
Contract Type FiledJune 14th, 2019 Company IndustryThis letter agreement amends and restates the offer letter between you and Morphic Holding, Inc. (the “Company”)1, dated June 16, 2015 (the “Prior Agreement”), effective as of the date immediately prior to the first date on which the Registration Statement on Form S-1 for the initial public offering of the Company’s common stock is declared effective by the United States Securities and Exchange Commission or, if later, the date that this Agreement is signed.
June 10, 2019 Alexey A. Lugovskoy, Ph.D. Dear Alex:Offer Letter • June 14th, 2019 • Morphic Holding, Inc. • Pharmaceutical preparations
Contract Type FiledJune 14th, 2019 Company IndustryThis letter agreement amends and restates the offer letter between you and Morphic Holding, Inc. (the “Company”)1, dated September 21, 2015 (the “Prior Agreement”), effective as of the date immediately prior to the first date on which the Registration Statement on Form S-1 for the initial public offering of the Company’s common stock is declared effective by the United States Securities and Exchange Commission or, if later, the date that this Agreement is signed.